Myocell Sciences: homepage concepts
Three directions built from the same content: real product data, cited studies and the research-use notice. Nothing is for sale on any of them.
Concept A · Clinical
Light, corporate and pharmaceutical: navy, one clinical blue, a serif display face. Leads with an evidence chart laid out like a drug-development pipeline, then the range, a vial-versus-pen comparison, quality and a research library.
Draws on: Pipeline charts from pharma sites; the lot-matched certificates and published testing of eppixlabs and omegagrade.Concept B · Specimen
Dark and lab-lit, built on the existing pen renders. One interactive panel holds the whole range: targets, research areas with evidence meters, and key specifications. Cited figures and a sample certificate follow.
Draws on: The specimen imagery, monospace data panels and featured-compound detail of omegagrade; pepdirect's pen-first framing.Concept C · Evidence first
Light, modern biotech. The evidence scale is introduced in the hero and reused throughout. Each compound gets a full tinted section with its mechanism, targets, one cited figure and graded research areas.
Draws on: peptideglobal's clean pen-led layout and compound-class guides, made more rigorous by grading every claim.